Bricef-T-1.125
Effective antibiotic for severe bacterial infections
Bricef-T-1.125 is a combination antibiotic injection used to treat severe bacterial infections, containing Ceftriaxone and Tazobactam.
Bricef T 1.125 is a potent combination antibiotic injection designed to combat severe bacterial infections. It combines Ceftriaxone, a third-generation cephalosporin, with Tazobactam, a beta-lactamase inhibitor, to enhance its effectiveness against resistant bacteria.
This medication is widely used in hospital settings for its broad-spectrum activity and is manufactured under strict quality standards to ensure safety and efficacy. Bricef T 1.125 is particularly effective for infections where other antibiotics may fail due to resistance.
Key Benefits:
- Broad-spectrum coverage against gram-positive and gram-negative bacteria
- Enhanced efficacy due to Tazobactam’s resistance-fighting properties
- Rapid action against severe infections
- Trusted for hospital-acquired infections
- Single-dose administration for ease of use
Active Ingredients:
| Ingredient | Amount per Vial | Function |
|---|---|---|
| Ceftriaxone | 1000 mg | Third-generation cephalosporin antibiotic that stops bacterial growth |
| Tazobactam | 125 mg | Beta-lactamase inhibitor that enhances Ceftriaxone’s effectiveness |
Contains no preservatives. Individuals with known allergies to cephalosporins or penicillins should consult their healthcare provider before use.
Recommended Uses:
Bricef T 1.125 is indicated for the treatment of severe bacterial infections, including:
- Complicated urinary tract infections
- Hospital-acquired pneumonia
- Intra-abdominal infections
- Bacterial meningitis
- Skin and soft tissue infections
- Septicemia
- Pre-surgical prophylaxis
Use only under medical supervision. Not suitable for viral infections like the common cold or flu.
Recommended Dosage:
Administration:
- Administer via intravenous (IV) or intramuscular (IM) injection by a healthcare professional
- Reconstitute with sterile water or saline as per instructions
- Administer slowly over 2-4 minutes (IV) to avoid irritation
Do not self-administer. Dosage and duration should be determined by a healthcare provider based on infection type and patient condition.
Common Side Effects:
- Pain or swelling at the injection site
- Nausea, vomiting, or diarrhea
- Mild rash or itching
Serious Side Effects (Seek Medical Attention Immediately):
- Severe allergic reactions (rash, swelling, difficulty breathing)
- Severe diarrhea (possible Clostridium difficile infection)
- Yellowing of skin or eyes (jaundice)
- Unusual bleeding or bruising
Contraindications:
Do NOT use Bricef T 1.125 if you:
- Have a known allergy to Ceftriaxone, Tazobactam, or other cephalosporins/penicillins
- Have severe liver or kidney impairment without medical supervision
- Are a neonate with jaundice or receiving calcium-containing IV fluids
Storage Conditions:
- Store at room temperature (15-25°C or 59-77°F)
- Protect from light and moisture
- Keep out of reach of children
- Store in the original vial until reconstitution
Shelf Life:
Bricef T 1.125 has a shelf life of 24 months from the date of manufacture when stored as recommended. Do not use after the expiration date.
Dispose of unused or expired medication through a pharmacy take-back program. Do not flush or discard in household trash.
Information provided is for educational purposes only. Always consult your healthcare provider before starting any medication. This product is available by prescription only in many countries. Follow your local regulations for proper acquisition and use of this medication.